Benefits and Barriers of Continuous Glucose Monitoring in Young Children with Type 1 Diabetes

Marisa E. Hilliard, Wendy Levy, Barbara J. Anderson, Amanda L. Whitehouse, Persis V. Commissariat, Kara R. Harrington, Lori M. Laffel, Kellee M. Miller, Michelle Van Name, William V. Tamborlane, Daniel J. Desalvo, Linda DiMeglio

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background: Continuous glucose monitoring (CGM) has potential to address challenges of type 1 diabetes (T1D) management for young children. CGM use is increasing, yet remains underutilized. Characterizing parents' experiences with CGM can inform clinical strategies to help parents make decisions about diabetes management, overcome obstacles to initiating and sustaining CGM use, and maximize benefits of CGM use in their children's diabetes care. Methods: Transcripts from semistructured qualitative interviews with 55 parents of children aged 1 to <8 years, with T1D duration ≥6 months, and whose child currently or previously used CGM were coded and analyzed to derive themes about their experiences with CGM. Results: Participants were 88% mothers and the mean child age was 5.0 ± 1.5 years. Parents described benefits of CGM use: decreased worry about glucose excursions, improved sleep, increased sense of safety with children who cannot recognize or express symptoms of hypo- or hyperglycemia, and greater comfort with other caregivers, especially using remote monitoring functionality when away from children. Challenges included painful insertions, wearing multiple devices on small bodies, disruptive alerts, data gaps due to lost signals, skin/adhesive problems, and difficulty interpreting the amount of information generated by CGM. For some, the challenges outweighed potential benefits and they stopped CGM use. Conclusions: CGM may address unique challenges of T1D in young children and increase parental comfort with diabetes management, yet there are multiple barriers to initiating or maintaining CGM use. Education and behavioral support to address these benefits and barriers may equip caregivers with skills to address challenges of CGM use.

Original languageEnglish (US)
Pages (from-to)493-498
Number of pages6
JournalDiabetes Technology and Therapeutics
Volume21
Issue number9
DOIs
StatePublished - Sep 1 2019

Fingerprint

Type 1 Diabetes Mellitus
Glucose
Parents
Caregivers
Child Care
Hypoglycemia
Hyperglycemia
Adhesives
Sleep
Mothers
Interviews

Keywords

  • Child
  • Health behavior
  • Parents
  • Type 1 diabetes

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology
  • Medical Laboratory Technology

Cite this

Hilliard, M. E., Levy, W., Anderson, B. J., Whitehouse, A. L., Commissariat, P. V., Harrington, K. R., ... DiMeglio, L. (2019). Benefits and Barriers of Continuous Glucose Monitoring in Young Children with Type 1 Diabetes. Diabetes Technology and Therapeutics, 21(9), 493-498. https://doi.org/10.1089/dia.2019.0142

Benefits and Barriers of Continuous Glucose Monitoring in Young Children with Type 1 Diabetes. / Hilliard, Marisa E.; Levy, Wendy; Anderson, Barbara J.; Whitehouse, Amanda L.; Commissariat, Persis V.; Harrington, Kara R.; Laffel, Lori M.; Miller, Kellee M.; Van Name, Michelle; Tamborlane, William V.; Desalvo, Daniel J.; DiMeglio, Linda.

In: Diabetes Technology and Therapeutics, Vol. 21, No. 9, 01.09.2019, p. 493-498.

Research output: Contribution to journalArticle

Hilliard, ME, Levy, W, Anderson, BJ, Whitehouse, AL, Commissariat, PV, Harrington, KR, Laffel, LM, Miller, KM, Van Name, M, Tamborlane, WV, Desalvo, DJ & DiMeglio, L 2019, 'Benefits and Barriers of Continuous Glucose Monitoring in Young Children with Type 1 Diabetes', Diabetes Technology and Therapeutics, vol. 21, no. 9, pp. 493-498. https://doi.org/10.1089/dia.2019.0142
Hilliard ME, Levy W, Anderson BJ, Whitehouse AL, Commissariat PV, Harrington KR et al. Benefits and Barriers of Continuous Glucose Monitoring in Young Children with Type 1 Diabetes. Diabetes Technology and Therapeutics. 2019 Sep 1;21(9):493-498. https://doi.org/10.1089/dia.2019.0142
Hilliard, Marisa E. ; Levy, Wendy ; Anderson, Barbara J. ; Whitehouse, Amanda L. ; Commissariat, Persis V. ; Harrington, Kara R. ; Laffel, Lori M. ; Miller, Kellee M. ; Van Name, Michelle ; Tamborlane, William V. ; Desalvo, Daniel J. ; DiMeglio, Linda. / Benefits and Barriers of Continuous Glucose Monitoring in Young Children with Type 1 Diabetes. In: Diabetes Technology and Therapeutics. 2019 ; Vol. 21, No. 9. pp. 493-498.
@article{c9fb9d429db343e48664dc9a402178fe,
title = "Benefits and Barriers of Continuous Glucose Monitoring in Young Children with Type 1 Diabetes",
abstract = "Background: Continuous glucose monitoring (CGM) has potential to address challenges of type 1 diabetes (T1D) management for young children. CGM use is increasing, yet remains underutilized. Characterizing parents' experiences with CGM can inform clinical strategies to help parents make decisions about diabetes management, overcome obstacles to initiating and sustaining CGM use, and maximize benefits of CGM use in their children's diabetes care. Methods: Transcripts from semistructured qualitative interviews with 55 parents of children aged 1 to <8 years, with T1D duration ≥6 months, and whose child currently or previously used CGM were coded and analyzed to derive themes about their experiences with CGM. Results: Participants were 88{\%} mothers and the mean child age was 5.0 ± 1.5 years. Parents described benefits of CGM use: decreased worry about glucose excursions, improved sleep, increased sense of safety with children who cannot recognize or express symptoms of hypo- or hyperglycemia, and greater comfort with other caregivers, especially using remote monitoring functionality when away from children. Challenges included painful insertions, wearing multiple devices on small bodies, disruptive alerts, data gaps due to lost signals, skin/adhesive problems, and difficulty interpreting the amount of information generated by CGM. For some, the challenges outweighed potential benefits and they stopped CGM use. Conclusions: CGM may address unique challenges of T1D in young children and increase parental comfort with diabetes management, yet there are multiple barriers to initiating or maintaining CGM use. Education and behavioral support to address these benefits and barriers may equip caregivers with skills to address challenges of CGM use.",
keywords = "Child, Health behavior, Parents, Type 1 diabetes",
author = "Hilliard, {Marisa E.} and Wendy Levy and Anderson, {Barbara J.} and Whitehouse, {Amanda L.} and Commissariat, {Persis V.} and Harrington, {Kara R.} and Laffel, {Lori M.} and Miller, {Kellee M.} and {Van Name}, Michelle and Tamborlane, {William V.} and Desalvo, {Daniel J.} and Linda DiMeglio",
year = "2019",
month = "9",
day = "1",
doi = "10.1089/dia.2019.0142",
language = "English (US)",
volume = "21",
pages = "493--498",
journal = "Diabetes Technology and Therapeutics",
issn = "1520-9156",
publisher = "Mary Ann Liebert Inc.",
number = "9",

}

TY - JOUR

T1 - Benefits and Barriers of Continuous Glucose Monitoring in Young Children with Type 1 Diabetes

AU - Hilliard, Marisa E.

AU - Levy, Wendy

AU - Anderson, Barbara J.

AU - Whitehouse, Amanda L.

AU - Commissariat, Persis V.

AU - Harrington, Kara R.

AU - Laffel, Lori M.

AU - Miller, Kellee M.

AU - Van Name, Michelle

AU - Tamborlane, William V.

AU - Desalvo, Daniel J.

AU - DiMeglio, Linda

PY - 2019/9/1

Y1 - 2019/9/1

N2 - Background: Continuous glucose monitoring (CGM) has potential to address challenges of type 1 diabetes (T1D) management for young children. CGM use is increasing, yet remains underutilized. Characterizing parents' experiences with CGM can inform clinical strategies to help parents make decisions about diabetes management, overcome obstacles to initiating and sustaining CGM use, and maximize benefits of CGM use in their children's diabetes care. Methods: Transcripts from semistructured qualitative interviews with 55 parents of children aged 1 to <8 years, with T1D duration ≥6 months, and whose child currently or previously used CGM were coded and analyzed to derive themes about their experiences with CGM. Results: Participants were 88% mothers and the mean child age was 5.0 ± 1.5 years. Parents described benefits of CGM use: decreased worry about glucose excursions, improved sleep, increased sense of safety with children who cannot recognize or express symptoms of hypo- or hyperglycemia, and greater comfort with other caregivers, especially using remote monitoring functionality when away from children. Challenges included painful insertions, wearing multiple devices on small bodies, disruptive alerts, data gaps due to lost signals, skin/adhesive problems, and difficulty interpreting the amount of information generated by CGM. For some, the challenges outweighed potential benefits and they stopped CGM use. Conclusions: CGM may address unique challenges of T1D in young children and increase parental comfort with diabetes management, yet there are multiple barriers to initiating or maintaining CGM use. Education and behavioral support to address these benefits and barriers may equip caregivers with skills to address challenges of CGM use.

AB - Background: Continuous glucose monitoring (CGM) has potential to address challenges of type 1 diabetes (T1D) management for young children. CGM use is increasing, yet remains underutilized. Characterizing parents' experiences with CGM can inform clinical strategies to help parents make decisions about diabetes management, overcome obstacles to initiating and sustaining CGM use, and maximize benefits of CGM use in their children's diabetes care. Methods: Transcripts from semistructured qualitative interviews with 55 parents of children aged 1 to <8 years, with T1D duration ≥6 months, and whose child currently or previously used CGM were coded and analyzed to derive themes about their experiences with CGM. Results: Participants were 88% mothers and the mean child age was 5.0 ± 1.5 years. Parents described benefits of CGM use: decreased worry about glucose excursions, improved sleep, increased sense of safety with children who cannot recognize or express symptoms of hypo- or hyperglycemia, and greater comfort with other caregivers, especially using remote monitoring functionality when away from children. Challenges included painful insertions, wearing multiple devices on small bodies, disruptive alerts, data gaps due to lost signals, skin/adhesive problems, and difficulty interpreting the amount of information generated by CGM. For some, the challenges outweighed potential benefits and they stopped CGM use. Conclusions: CGM may address unique challenges of T1D in young children and increase parental comfort with diabetes management, yet there are multiple barriers to initiating or maintaining CGM use. Education and behavioral support to address these benefits and barriers may equip caregivers with skills to address challenges of CGM use.

KW - Child

KW - Health behavior

KW - Parents

KW - Type 1 diabetes

UR - http://www.scopus.com/inward/record.url?scp=85071178682&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071178682&partnerID=8YFLogxK

U2 - 10.1089/dia.2019.0142

DO - 10.1089/dia.2019.0142

M3 - Article

C2 - 31287721

AN - SCOPUS:85071178682

VL - 21

SP - 493

EP - 498

JO - Diabetes Technology and Therapeutics

JF - Diabetes Technology and Therapeutics

SN - 1520-9156

IS - 9

ER -